Contraception
Volume 81, Issue 5 , Pages 452-453 , May 2010

ORTHO EVRA® and venous thromboembolism: an update

Received 30 November 2009 ,Revised 16 December 2009 ,Accepted 16 December 2009.

References 

  1. Jick SS, Kaye JA, Russmann S, Jick H. Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 μg of ethinyl estradiol. Contraception. 2006;73:223–228
  2. Jick SS, Kaye JA, Li L, Jick H. Further results on the risk of nonfatal venous thromboembolism in users of the contraceptive transdermal patch compared to users of oral contraceptives containing norgestimate and 35 μg of ethinyl estradiol. Contraception. 2007;76:4–7

☆ This study was funded by a grant from Johnson and Johnson Pharmaceutical Research and Development.

PII: S0010-7824(09)00542-3

doi: 10.1016/j.contraception.2009.12.016

Contraception
Volume 81, Issue 5 , Pages 452-453 , May 2010

Article Tools